EXA Stock Price, News & Analysis (NASDAQ:EXA)

$24.24 0.01 (0.04 %)
(As of 01/23/2018 06:09 AM ET)
Previous Close$24.23
Today's Range$24.23 - $24.24
52-Week Range$12.34 - $24.42
Volume63,500 shs
Average Volume100,740 shs
Market Capitalization$363.92 million
P/E Ratio-78.19
Dividend YieldN/A
Beta0.63

About EXA (NASDAQ:EXA)

EXA logoExa Corporation develops, sells and supports simulation software and services that manufacturers use in design and engineering processes. The Company focuses primarily on the ground transportation market, including manufacturers in the passenger vehicle, highway truck, off-highway vehicle and train markets, as well as their suppliers. Its product, PowerFLOW, is a software solution for simulating fluid flow problems, including aerodynamics, thermal management and aeroacoustics, or wind noise. PowerFLOW uses its Digital Physics technology that enables it to predict fluid flows. PowerFLOW directly simulates unpredictable turbulent scales. The PowerFLOW software suite includes the simulation engine and grid generation engine, along with pre- and post-processing software products. The software is delivered in client/server architecture, or through its cloud-based offering, ExaCLOUD. With the ExaCLOUD solution, various client features and functions are accessed through a Web browser.

Receive EXA News and Ratings via Email

Sign-up to receive the latest news and ratings for EXA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Software
Sub-IndustryApplication Software
SectorTechnology
SymbolNASDAQ:EXA
CUSIP30061450
Phone+1-781-6768500

Debt

Debt-to-Equity Ratio0.01%
Current Ratio1.06%
Quick Ratio1.06%

Price-To-Earnings

Trailing P/E Ratio-78.1935483870968
Forward P/E Ratio-71.29
P/E GrowthN/A

Sales & Book Value

Annual Sales$72.58 million
Price / Sales5.04
Cash Flow$0.21 per share
Price / Cash113.69
Book Value$1.29 per share
Price / Book18.79

Profitability

Trailing EPS($0.31)
Net Income$-1,130,000.00
Net Margins-15.10%
Return on Equity-62.82%
Return on Assets-18.57%

Miscellaneous

Employees345
Outstanding Shares15,100,000

EXA (NASDAQ:EXA) Frequently Asked Questions

What is EXA's stock symbol?

EXA trades on the NASDAQ under the ticker symbol "EXA."

How were EXA's earnings last quarter?

Exa Corp (NASDAQ:EXA) issued its earnings results on Wednesday, May, 24th. The technology company reported ($0.14) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.18) by $0.04. The technology company earned $16.56 million during the quarter, compared to analysts' expectations of $16.56 million. EXA had a negative return on equity of 62.82% and a negative net margin of 15.10%. The firm's quarterly revenue was down 1.4% on a year-over-year basis. During the same period in the prior year, the business earned ($0.04) EPS. View EXA's Earnings History.

Where is EXA's stock going? Where will EXA's stock price be in 2018?

4 equities research analysts have issued twelve-month target prices for EXA's stock. Their forecasts range from $16.00 to $24.25. On average, they expect EXA's stock price to reach $20.63 in the next twelve months. View Analyst Ratings for EXA.

What are Wall Street analysts saying about EXA stock?

Here are some recent quotes from research analysts about EXA stock:

  • 1. According to Zacks Investment Research, "Exa Corporation develops, markets, sells, and supports software products, and provides professional services for simulation-driven design. The Company offers PowerFLOW(R) simulation engine, automatic fluid grid generation engine, mesh preparation, advanced simulation analysis, and rapid design geometry modification products. The company's software suite includes PowerDELTA, PowerCASE, PowerCLAY, PowerTHERM, PowerCOOL, PowerINSIGHT, PowerVIZ and PowerACOUSTICS. Its products are used in various applications, including aerodynamics, thermal management, aeroacoustics, climate control, and powertrain. . Exa Corporation is headquartered in Burlington, Massachusetts. " (10/31/2017)
  • 2. Stifel Nicolaus analysts commented, "Exa reported mixed F4Q17 results that came in below consensus on the top line and towards the lower end of management's guided range. Specifically, total revenue of $19.5M was up just 6% Y/Y in C.C. despite facing its easiest comp of the year, and fell well short of our $20.6M estimate. By product line, license revenue of $16M (up 11% Y/Y in C.C.) missed our number by ~$500K, while project revenue of $3.5M (down 11% Y/Y in C.C.) came up ~$600K short of our estimate. The silver lining to this sharp fall in product revenue is that Exa's license revenue, which is recurring in nature and carries a much more favorable gross margin profile, grew to represent a large proportion of the overall mix and helped drive adjusted EBITDA of $2.7M that came in ~$700K above our estimate." (3/17/2017)
  • 3. Needham & Company LLC analysts commented, "Exa delivered mixed F4Q17 results, but the more disappointing was F18 guidance, which was materially weaker (~4-5% less y/y growth) than that issued, albeit in preliminary fashion, at the company's mid-December analyst day. The weakness was attributed to hesitation by auto and truck OEMs related to uncertainty in US policy regarding a potential border tax and looser emissions regulations. In theory at least some of this hesitation should ease with more clarity regarding US policy, and management noted that product usage had not slowed, suggesting potential for stronger F2H18 renewals if this were to continue. As such, while we're clearly disappointed with the reduced outlook, we maintain our Buy rating for now (PT reduced to $16, or 2.8x EV/F18 sales, from $18) as we look for evidence of improving demand in F2H18." (3/17/2017)

Who are some of EXA's key competitors?

Who are EXA's key executives?

EXA's management team includes the folowing people:

  • John J. Shields III, Independent Chairman of the Board (Age 76)
  • Stephen A. Remondi, President, Chief Executive Officer, Director (Age 50)
  • Richard F. Gilbody, Chief Financial Officer (Age 55)
  • Hudong Chen Ph.D., Senior Vice President, Chief Scientific Officer (Age 58)
  • Suresh Sundaram, Senior Vice President, Products and Marketing
  • James E Hoch, Senior Vice President - Software Development (Age 50)
  • Joel F. Dube, Principal Accounting Officer, Vice President - Finance
  • Jean-Paul Roux, Vice President - European Operations (Age 51)
  • Robert D. Burke, Independent Director (Age 60)
  • Mark E. Fusco, Independent Director (Age 52)

How do I buy EXA stock?

Shares of EXA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is EXA's stock price today?

One share of EXA stock can currently be purchased for approximately $24.24.

How big of a company is EXA?

EXA has a market capitalization of $363.92 million and generates $72.58 million in revenue each year. The technology company earns $-1,130,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. EXA employs 345 workers across the globe.

How can I contact EXA?

EXA's mailing address is 55 Network Dr, BURLINGTON, MA 01803-2756, United States. The technology company can be reached via phone at +1-781-6768500 or via email at [email protected]


MarketBeat Community Rating for EXA (EXA)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  158 (Vote Outperform)
Underperform Votes:  102 (Vote Underperform)
Total Votes:  260
MarketBeat's community ratings are surveys of what our community members think about EXA and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

EXA (NASDAQ:EXA) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.002.002.002.75
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $20.63$20.63$20.63$16.50
Price Target Upside: 14.70% downside14.70% downside14.70% downside5.16% upside

EXA (NASDAQ:EXA) Consensus Price Target History

Price Target History for EXA (NASDAQ:EXA)

EXA (NASDAQ:EXA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/29/2017Needham & Company LLCDowngradeBuy -> HoldLowView Rating Details
9/28/2017Canaccord GenuityReiterated RatingHold$24.25LowView Rating Details
9/28/2017Stifel NicolausDowngradeBuy -> Hold$17.00 -> $24.25LowView Rating Details
9/28/2017Robert W. BairdDowngradeOutperform -> NeutralLowView Rating Details
(Data available from 1/23/2016 forward)

Earnings

EXA (NASDAQ:EXA) Earnings History and Estimates Chart

Earnings by Quarter for EXA (NASDAQ:EXA)

EXA (NASDAQ EXA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/28/2017Q2 2018($0.12)($0.12)$17.58 million$17.50 millionViewN/AView Earnings Details
5/24/2017Q1 2018($0.18)($0.14)$16.56 million$16.56 millionViewN/AView Earnings Details
3/16/2017Q4 2017$0.00$0.03$20.25 million$19.53 millionViewN/AView Earnings Details
11/30/2016Q3 2017($0.01)$0.04$19.10 million$19.20 millionViewN/AView Earnings Details
8/29/2016Q217($0.06)($0.02)$17.32 million$17.11 millionViewListenView Earnings Details
5/25/2016Q1($0.08)($0.04)$16.68 million$16.80 millionViewListenView Earnings Details
3/10/2016Q416($0.15)($0.06)$17.72 million$18.30 millionViewListenView Earnings Details
12/3/2015Q316($0.05)($0.03)$16.87 million$17.00 millionViewListenView Earnings Details
9/1/2015Q216($0.08)($0.06)$15.53 million$15.50 millionViewListenView Earnings Details
5/28/2015Q116($0.14)($0.10)$14.65 million$14.80 millionViewListenView Earnings Details
3/19/2015Q415($0.01)($0.04)$16.74 million$16.86 millionViewN/AView Earnings Details
12/4/2014Q315$0.03$0.04$16.20 million$15.96 millionViewN/AView Earnings Details
8/27/2014Q215($0.03)($0.06)$14.48 million$14.80 millionViewN/AView Earnings Details
5/29/2014Q115($0.04)($1.27)$13.94 million$13.80 millionViewN/AView Earnings Details
3/24/2014Q414$0.03$0.03$14.70 million$15.20 millionViewN/AView Earnings Details
12/4/2013Q3$0.04$0.05$13.72 million$14.10 millionViewListenView Earnings Details
9/4/2013Q2 2014($0.04)($0.04)$13.08 million$12.70 millionViewN/AView Earnings Details
6/4/2013Q1 2014($0.04)($0.02)$12.17 million$12.50 millionViewN/AView Earnings Details
3/27/2013Q4 2013$0.03($0.01)$12.32 million$13.10 millionViewN/AView Earnings Details
12/3/20120.00$0.02$12.70 millionViewN/AView Earnings Details
9/6/2012Q213$0.02$0.10$11.89 million$11.80 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

EXA (NASDAQ:EXA) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.34 EPS
Next Year EPS Consensus Estimate: $-0.09 EPS

Dividends

Dividend History for EXA (NASDAQ:EXA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

EXA (NASDAQ EXA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 11.53%
Institutional Ownership Percentage: 74.37%
Insider Trades by Quarter for EXA (NASDAQ:EXA)
Institutional Ownership by Quarter for EXA (NASDAQ:EXA)

EXA (NASDAQ EXA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/26/2017Soros Fund Management LlcMajor ShareholderBuy14,119$16.58$234,093.02View SEC Filing  
9/25/2017Soros Fund Management LlcMajor ShareholderBuy700$16.15$11,305.00View SEC Filing  
9/21/2017Soros Fund Management LlcMajor ShareholderBuy15,489$15.99$247,669.11View SEC Filing  
9/18/2017Soros Fund Management LlcMajor ShareholderBuy53,502$15.49$828,745.98View SEC Filing  
9/13/2017Soros Fund Management LlcMajor ShareholderBuy159,500$14.46$2,306,370.00View SEC Filing  
6/1/2017John J ShieldsDirectorSell1,000$13.89$13,890.0053,078View SEC Filing  
5/1/2017John J ShieldsDirectorSell1,000$13.75$13,750.0054,078View SEC Filing  
4/3/2017John J ShieldsDirectorSell1,000$12.80$12,800.0055,078View SEC Filing  
3/1/2017John J ShieldsDirectorSell1,000$15.74$15,740.0056,078View SEC Filing  
2/1/2017John J ShieldsDirectorSell1,000$15.60$15,600.0057,078View SEC Filing  
1/3/2017John J ShieldsDirectorSell1,000$15.33$15,330.0058,078View SEC Filing  
12/20/2016Hudong ChenInsiderSell3,000$16.00$48,000.00119,656View SEC Filing  
12/20/2016James E HochVPSell12,000$16.00$192,000.00153,694View SEC Filing  
12/1/2016John J ShieldsDirectorSell1,000$15.00$15,000.0059,078View SEC Filing  
11/1/2016John J ShieldsDirectorSell1,000$14.00$14,000.0060,078View SEC Filing  
10/7/2016Wayne D MackieDirectorBuy10,565$14.91$157,524.1569,723View SEC Filing  
10/6/2016Fidelity Non-Profit ManagementMajor ShareholderSell1,200,000$14.72$17,664,000.00905,640View SEC Filing  
10/3/2016John J ShieldsDirectorSell1,000$16.03$16,030.0061,078View SEC Filing  
9/1/2016John J ShieldsDirectorSell1,000$15.62$15,620.0062,778View SEC Filing  
8/1/2016John J ShieldsDirectorSell2,000$14.37$28,740.0064,078View SEC Filing  
7/25/2016John J ShieldsDirectorSell4,699$13.96$65,598.0465,078View SEC Filing  
7/1/2016Stephen A RemondiCEOSell10,000$14.45$144,500.00356,974View SEC Filing  
6/6/2016Stephen A RemondiCEOSell4,001$11.52$46,091.52369,974View SEC Filing  
6/3/2016Stephen A RemondiCEOSell5,999$11.84$71,028.16375,361View SEC Filing  
5/4/2016Stephen A RemondiCEOSell10,000$13.07$130,700.00383,732View SEC Filing  
5/3/2016Stephen A RemondiCEOSell3,363$13.09$44,021.67383,732View SEC Filing  
5/2/2016Stephen A RemondiCEOSell3,242$13.20$42,794.40383,732View SEC Filing  
4/4/2016Stephen A RemondiCEOSell10,000$12.94$129,400.00393,120View SEC Filing  
3/21/2016Hudong ChenVPSell20,000$12.01$240,200.0074,426View SEC Filing  
3/14/2016James E HochVPSell8,000$11.50$92,000.0096,464View SEC Filing  
3/1/2016Stephen A RemondiCEOSell10,000$10.64$106,400.00401,974View SEC Filing  
2/24/2016Hudong ChenVPSell10,000$10.61$106,100.00105,926View SEC Filing  
2/2/2016Stephen A. RemondiCEOSell10,000$10.76$107,600.00406,974View SEC Filing  
1/8/2016James E HochVPSell4,000$11.50$46,000.00104,464View SEC Filing  
1/5/2016Stephen A. RemondiCEOSell10,000$11.57$115,700.00416,974View SEC Filing  
1/5/2016Wayne D MackieDirectorBuy5,000$11.58$57,900.0065,148View SEC Filing  
1/4/2016Stephen A. RemondiCEOSell2,754$11.46$31,560.84416,974View SEC Filing  
12/31/2015James E. HochVPSell4,000$11.50$46,000.00108,464View SEC Filing  
12/22/2015Stephen A. RemondiCEOSell10,000$11.00$110,000.00426,974View SEC Filing  
12/21/2015Richard F. GilbodyCFOBuy10,000$10.92$109,200.0020,000View SEC Filing  
12/16/2015Wayne D. MackieDirectorBuy3,375$10.44$35,235.0054,713View SEC Filing  
12/15/2015Wayne D. MackieDirectorBuy10,000$10.08$100,800.0054,713View SEC Filing  
12/14/2015Wayne D. MackieDirectorBuy3,175$10.09$32,035.7554,713View SEC Filing  
11/3/2015Stephen A. RemondiCEOSell10,000$9.68$96,800.00436,974View SEC Filing  
10/7/2015Stephen A. RemondiCEOSell10,000$10.02$100,200.00446,974View SEC Filing  
10/6/2015Stephen A. RemondiCEOSell6,623$10.00$66,230.00446,974View SEC Filing  
10/5/2015Stephen A. RemondiCEOSell800$10.15$8,120.00446,974View SEC Filing  
9/2/2015Stephen A RemondiCEOSell10,000$10.51$105,100.00456,974View SEC Filing  
7/6/2015Stephen A RemondiCEOSell10,000$11.06$110,600.00View SEC Filing  
6/11/2015John J ShieldsDirectorSell4,600$11.36$52,256.00View SEC Filing  
6/9/2015John J ShieldsDirectorSell5,400$11.50$62,100.00View SEC Filing  
6/4/2015Stephen A RemondiCEOSell10,000$10.85$108,500.00View SEC Filing  
5/5/2015Stephen A RemondiCEOSell8,884$10.94$97,190.96View SEC Filing  
4/16/2015Wayne D MackieDirectorBuy12,000$10.79$129,480.00View SEC Filing  
4/2/2015Stephen A RemondiCEOSell10,000$11.64$116,400.00View SEC Filing  
3/9/2015Stephen A RemondiCEOSell6,423$10.00$64,230.00View SEC Filing  
3/6/2015Stephen A RemondiCEOSell3,577$10.16$36,342.32View SEC Filing  
2/9/2015Stephen A RemondiCEOSell4,802$10.23$49,124.46View SEC Filing  
2/4/2015Stephen A RemondiCEOSell5,198$10.22$53,123.56View SEC Filing  
2/3/2015Stephen A RemondiCEOSell1,489$10.21$15,202.69View SEC Filing  
2/2/2015Stephen A RemondiCEOSell2,109$10.24$21,596.16View SEC Filing  
1/9/2015Stephen A RemondiCEOSell10,000$10.79$107,900.00View SEC Filing  
12/22/2014Stephen A RemondiCEOSell10,000$11.12$111,200.00View SEC Filing  
11/6/2014Stephen A RemondiCEOSell10,000$9.97$99,700.00View SEC Filing  
10/1/2014Stephen A RemondiCEOSell10,000$11.30$113,000.00View SEC Filing  
9/2/2014Stephen A RemondiCEOSell10,000$12.02$120,200.00View SEC Filing  
8/1/2014Stephen A RemondiCEOSell10,000$9.25$92,500.00View SEC Filing  
7/1/2014Stephen A RemondiCEOSell10,000$11.11$111,100.00View SEC Filing  
6/17/2014Jean-Paul RouxVPBuy2,000$9.44$18,880.00View SEC Filing  
6/9/2014John William Sr Poduska SrDirectorBuy2,793$8.90$24,857.70View SEC Filing  
6/4/2014Stephen A RemondiCEOSell10,000$9.12$91,200.00View SEC Filing  
5/1/2014Stephen RemondiCEOSell10,000$10.90$109,000.00182,359View SEC Filing  
4/10/2014Stephen SarnoCFOBuy1,000$11.98$11,980.0016,000View SEC Filing  
4/4/2014John William Sr Poduska, Sr.DirectorBuy1,600$12.71$20,336.0047,207View SEC Filing  
4/4/2014Stephen RemondiCEOSell2,500$12.72$31,800.00192,359View SEC Filing  
4/3/2014Stephen RemondiCEOSell7,500$13.13$98,475.00194,859View SEC Filing  
4/1/2014John William Sr Poduska, Sr.DirectorBuy1,000$13.31$13,310.0046,607View SEC Filing  
3/28/2014John William Sr Poduska, Sr.DirectorBuy6,300$13.39$84,357.0045,607View SEC Filing  
3/25/2014James HochVPSell1,300$15.75$20,475.0035,541View SEC Filing  
3/4/2014Stephen RemondiCEOSell10,000$14.75$147,500.0052,359View SEC Filing  
1/6/2014Stephen RemondiCEOSell10,000$13.31$133,100.0072,359View SEC Filing  
12/20/2013Stephen RemondiCEOSell10,000$13.08$130,800.0082,359View SEC Filing  
12/17/2013John William Sr Poduska, Sr.DirectorBuy4,607$13.53$62,332.7141,607View SEC Filing  
10/2/2013Jean-Paul RouxVPBuy2,000$15.17$30,340.00130,289View SEC Filing  
10/2/2013Stephen A RemondiCEOSell10,000$15.14$151,400.00View SEC Filing  
9/18/2013John William Sr Poduska, Sr.DirectorBuy11,821$15.62$184,644.0239,000View SEC Filing  
9/13/2013John William Sr Poduska, Sr.DirectorBuy6,170$13.96$86,133.2031,009View SEC Filing  
9/4/2013Stephen A RemondiCEOSell10,000$13.78$137,800.00View SEC Filing  
8/2/2013Stephen RemondiCEOSell10,000$11.50$115,000.00112,359View SEC Filing  
7/12/2013John William Sr Poduska SrDirectorBuy5,009$10.26$51,392.34View SEC Filing  
7/2/2013Stephen A RemondiCEOSell10,000$10.61$106,100.00View SEC Filing  
6/3/2013Stephen A RemondiCEOSell10,000$8.32$83,200.00View SEC Filing  
4/9/2013John William Sr Poduska SrDirectorBuy6,000$7.55$45,300.00View SEC Filing  
4/8/2013Stephen P SarnoInsiderBuy5,000$7.50$37,500.00View SEC Filing  
4/5/2013Edmond L FurlongCFOBuy10,000$7.55$75,500.00View SEC Filing  
4/4/2013John F Smith JrDirectorBuy4,000$8.10$32,400.00View SEC Filing  
2/1/2013Stephen A RemondiCEOSell10,000$9.81$98,100.00View SEC Filing  
1/17/2013Edmond L FurlongCFOBuy15,998$9.95$159,180.10View SEC Filing  
1/11/2013Edmond L FurlongCFOBuy5,973$9.57$57,161.61View SEC Filing  
1/9/2013Stephen P SarnoInsiderBuy10,000$9.34$93,400.00View SEC Filing  
1/4/2013John William Sr Poduska SrDirectorBuy20,000$9.73$194,600.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

EXA (NASDAQ EXA) News Headlines

Source:
DateHeadline
Colorectal Cancer Alliance-Funded Research among First to Examine Relationship between Colon Microbiota and Colorectal CancerColorectal Cancer Alliance-Funded Research among First to Examine Relationship between Colon Microbiota and Colorectal Cancer
www.prnewswire.com - January 23 at 6:23 AM
Exact Sciences under pressure on potential CRC blood screening test; shares down 9%Exact Sciences under pressure on potential CRC blood screening test; shares down 9%
seekingalpha.com - January 17 at 11:23 AM
Head to Head Survey: Attunity (ATTU) and EXA (EXA)Head to Head Survey: Attunity (ATTU) and EXA (EXA)
www.americanbankingnews.com - January 16 at 7:56 PM
Exa Corp (EXA) Receives Consensus Recommendation of "Hold" from BrokeragesExa Corp (EXA) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - January 16 at 4:02 AM
Exact Sciences Announces Upsize and Pricing of $600 Million of 1.0% Convertible Senior Notes Due 2025Exact Sciences Announces Upsize and Pricing of $600 Million of 1.0% Convertible Senior Notes Due 2025
www.prnewswire.com - January 11 at 10:20 PM
3 Slides That Paint a Great Picture for Exact Sciences Future3 Slides That Paint a Great Picture for Exact Sciences' Future
www.fool.com - January 10 at 9:19 AM
Global IoT Markets Dataset & Report 2017: Technologies & Market Forecasts up to 2030 - Examination of Market Trends in 14 Major VerticalsGlobal IoT Markets Dataset & Report 2017: Technologies & Market Forecasts up to 2030 - Examination of Market Trends in 14 Major Verticals
www.prnewswire.com - January 8 at 12:32 PM
Exact Sciences to report $265.5-266.5 million in revenue, 168 percent growth for 2017Exact Sciences to report $265.5-266.5 million in revenue, 168 percent growth for 2017
www.prnewswire.com - January 7 at 2:10 PM
The Cryptocurrency Market Isnt Fair, Which Is Exactly Why Its So Successful The Cryptocurrency Market Isn't Fair, Which Is Exactly Why It's So Successful
www.fool.com - January 6 at 12:53 PM
UPDATE - CCEI Offers No-Cost Online Course Examining The Mentoring Process: Developing Professionalism from WithinUPDATE - CCEI Offers No-Cost Online Course Examining The Mentoring Process: Developing Professionalism from Within
feeds.benzinga.com - January 3 at 12:26 PM
Pesquera Exalmar S.A.A. Announces Exchange Offer And Consent Solicitation For Any And All Of Its 7.375% Senior Notes Due 2020Pesquera Exalmar S.A.A. Announces Exchange Offer And Consent Solicitation For Any And All Of Its 7.375% Senior Notes Due 2020
www.prnewswire.com - December 22 at 8:13 PM
Exa Corp (EXA) Receives Consensus Rating of "Hold" from BrokeragesExa Corp (EXA) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - December 22 at 3:58 AM
New National Study Examines 2017 U.S. Physician Employment and Compensation GrowthNew National Study Examines 2017 U.S. Physician Employment and Compensation Growth
www.prnewswire.com - December 19 at 5:19 AM
République owners opening restaurant in downtown L.A.s historic Herald Examiner buildingRépublique owners opening restaurant in downtown L.A.'s historic Herald Examiner building
www.latimes.com - December 7 at 6:49 AM
500,000 New Biometric Drivers Licenses per Month500,000 New Biometric Driver's Licenses per Month
www.prnewswire.com - December 6 at 5:52 AM
500.000 novas carteiras de motorista com identificação biométrica por mês500.000 novas carteiras de motorista com identificação biométrica por mês
www.prnewswire.com - December 6 at 5:52 AM
Sino-British Academic Exchanges Take Step Forward in English AssessmentSino-British Academic Exchanges Take Step Forward in English Assessment
www.prnewswire.com - December 6 at 4:02 AM
Bitcoin rebounds, surges above $11,700 for yet another recordBitcoin rebounds, surges above $11,700 for yet another record
www.marketwatch.com - December 3 at 7:27 PM
Global Cloud Based Simulation Application Market: Deployment Across Various Industry Verticals to Stimulate Growth - Transparency Market ResearchGlobal Cloud Based Simulation Application Market: Deployment Across Various Industry Verticals to Stimulate Growth - Transparency Market Research
www.prnewswire.com - December 2 at 9:18 AM
CCEI Offers No-Cost Online Course Examining Inclusion and Children with Special NeedsCCEI Offers No-Cost Online Course Examining Inclusion and Children with Special Needs
feeds.benzinga.com - December 1 at 3:53 AM
Do Consumers Know Exactly How Much They Are Paying? New Research From Columbia Business School Shows The Impact Of Hidden Fees On The Shopping ExperienceDo Consumers Know Exactly How Much They Are Paying? New Research From Columbia Business School Shows The Impact Of Hidden Fees On The Shopping Experience
www.prnewswire.com - November 29 at 12:46 PM
State Policymakers to Examine Future of Sports Betting at Miami Meeting of Legislators from Gaming StatesState Policymakers to Examine Future of Sports Betting at Miami Meeting of Legislators from Gaming States
www.prnewswire.com - November 28 at 11:28 AM
Pivotal Trial Data Support Potential of Seno Medical Instruments Imagio™ Opto-Acoustic Breast Imaging System in Reducing False Positive Breast Examinations and Benign BiopsiesPivotal Trial Data Support Potential of Seno Medical Instruments' Imagio™ Opto-Acoustic Breast Imaging System in Reducing False Positive Breast Examinations and Benign Biopsies
www.prnewswire.com - November 27 at 7:52 PM
Exa Corporation (EXA) Receives Average Rating of "Hold" from BrokeragesExa Corporation (EXA) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - November 27 at 4:10 AM
Global $7.65 Billion Specialty Medical Chairs Market 2014-2017 & 2025  - Examination Chairs, Treatment Chairs, Rehabilitation ChairsGlobal $7.65 Billion Specialty Medical Chairs Market 2014-2017 & 2025 - Examination Chairs, Treatment Chairs, Rehabilitation Chairs
www.prnewswire.com - November 24 at 12:16 PM
Featured Company News - Dassault Systèmes Completes Acquisition of Exa Following Completion of Tender Offer for Exas SharesFeatured Company News - Dassault Systèmes Completes Acquisition of Exa Following Completion of Tender Offer for Exa's Shares
finance.yahoo.com - November 21 at 6:41 PM
Exa Corporation (EXA) Scheduled to Post Earnings on TuesdayExa Corporation (EXA) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - November 21 at 1:30 AM
UPDATE: Dassault Systemes Completes Tender Offer for Exa Corporation (EXA)UPDATE: Dassault Systemes Completes Tender Offer for Exa Corporation (EXA)
www.streetinsider.com - November 18 at 3:20 AM
Should You Buy Exa Corporation (EXA) At $24.235?Should You Buy Exa Corporation (EXA) At $24.235?
finance.yahoo.com - November 17 at 12:14 PM
The Industrys First Noise-Tolerant Opamps from ROHMThe Industry's First Noise-Tolerant Opamps from ROHM
feeds.benzinga.com - November 16 at 11:11 AM
$20.40 Million in Sales Expected for Exa Corporation (EXA) This Quarter$20.40 Million in Sales Expected for Exa Corporation (EXA) This Quarter
www.americanbankingnews.com - November 11 at 8:30 AM
Key Words: Invoking Mary, Joseph and Jesus to defend Roy Moore?Key Words: Invoking Mary, Joseph and Jesus to defend Roy Moore?
www.marketwatch.com - November 10 at 11:19 AM
The Republican Tax Bill Exacerbated Teslas Drop YesterdayThe Republican Tax Bill Exacerbated Tesla's Drop Yesterday
www.fool.com - November 3 at 12:38 PM
Exa Launches DigitalROCK on the Cloud for Enhanced Oil Reservoir PerformanceExa Launches DigitalROCK on the Cloud for Enhanced Oil Reservoir Performance
finance.yahoo.com - November 2 at 7:40 PM
Exa Corporation (EXA) Given Consensus Rating of "Hold" by BrokeragesExa Corporation (EXA) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - November 2 at 1:46 AM
Zacks Investment Research Upgrades Exa Corporation (EXA) to "Hold"Zacks Investment Research Upgrades Exa Corporation (EXA) to "Hold"
www.americanbankingnews.com - October 31 at 11:22 PM
Why Exact Sciences Shares Are Soaring 11.6% TodayWhy Exact Sciences Shares Are Soaring 11.6% Today
www.fool.com - October 31 at 3:15 PM
Exact Sciences Shares Higher After Q3 Beat And RaiseExact Sciences Shares Higher After Q3 Beat And Raise
feeds.benzinga.com - October 31 at 12:44 PM
Exact Sciences Earnings Hammer Short-Sellers (Again)Exact Sciences' Earnings Hammer Short-Sellers (Again)
www.fool.com - October 31 at 10:28 AM
Trump Is Expected to Name Jerome Powell as Next Fed Chairman - New York TimesTrump Is Expected to Name Jerome Powell as Next Fed Chairman - New York Times
www.nytimes.com - October 30 at 4:50 PM
The New York Post: Trump dossier was originally funded by conservative website Washington Free Beacon: reportThe New York Post: Trump dossier was originally funded by conservative website Washington Free Beacon: report
www.marketwatch.com - October 27 at 8:46 PM
Dassault Systèmes (DASTY) CEO Bernard Charlès on Q3 2017 Results - Earnings Call TranscriptDassault Systèmes' (DASTY) CEO Bernard Charlès on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - October 26 at 12:34 PM
The GOPs Big Lie About Tax Cuts - HuffPostThe GOP's Big Lie About Tax Cuts - HuffPost
www.huffingtonpost.com - October 24 at 2:05 AM
Exa Corporation (EXA) Rating Lowered to Hold at BidaskClubExa Corporation (EXA) Rating Lowered to Hold at BidaskClub
www.americanbankingnews.com - October 22 at 12:54 PM
Exa Corporation (EXA) Expected to Announce Quarterly Sales of $20.40 MillionExa Corporation (EXA) Expected to Announce Quarterly Sales of $20.40 Million
www.americanbankingnews.com - October 22 at 3:54 AM
Key Words: 41-year-old Donald Trump’s take on Black Monday? Exactly what you’d expect it to beKey Words: 41-year-old Donald Trump’s take on Black Monday? Exactly what you’d expect it to be
www.marketwatch.com - October 19 at 11:51 AM
EQUITY ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Exa Corporation to Dassault Systèmes for $24.25 Per Share is Fair to Shareholders - EXAEQUITY ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Exa Corporation to Dassault Systèmes for $24.25 Per Share is Fair to Shareholders - EXA
finance.yahoo.com - October 18 at 7:55 PM
The Law Offices of Vincent Wong Reminds Investors of an Investigation of Exa Corporation in Connection with the Sale of the Company to Dassault SystèmesThe Law Offices of Vincent Wong Reminds Investors of an Investigation of Exa Corporation in Connection with the Sale of the Company to Dassault Systèmes
finance.yahoo.com - October 16 at 6:55 PM
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Exa Corporation - EXASHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Exa Corporation - EXA
finance.yahoo.com - October 13 at 9:07 PM
Exact Sciences Stock Just Hit an All-Time High: Heres Why It Could Go Even HigherExact Sciences Stock Just Hit an All-Time High: Here's Why It Could Go Even Higher
www.fool.com - October 13 at 7:38 AM

SEC Filings

EXA (NASDAQ:EXA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

EXA (NASDAQ:EXA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

EXA (NASDAQ EXA) Stock Chart for Tuesday, January, 23, 2018

Loading chart…

This page was last updated on 1/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.